Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03074006 · ClinicalTrials.gov registry record · Phase 1
Dose Escalation and Proof-of-Concept Studies of Vactosertib (TEW-7197) Monotherapy in Patients With MDS
A Phase 1 study, sponsored by MedPacto.
- Completed
- Registry status
- Phase 1
- Development phase
- 9
- Enrollment target
NCT03074006 is a Phase 1 study that has completed, run by MedPacto. The registered enrollment target is 9 participants.
The verdict
NCT03074006, a Phase 1 study, has completed, sponsored by MedPacto.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 9 participants
- Enrollment target
Study Summary
This is a prospective, open-label, multicenter, phase 1/2 study of TEW-7197 in patients with low and intermediate risk of myelodysplastic syndrome (MDS).
Interventions
- DRUG TEW-7197
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2018-01-04 |
| Est. Completion | 2019-12-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03074006
The ClinicalTrials.gov registry entry for NCT03074006 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MedPacto, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TEW-7197 is the first listed.
NCT03074006 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03074006 about?
NCT03074006 is a clinical study titled "Dose Escalation and Proof-of-Concept Studies of Vactosertib (TEW-7197) Monotherapy in Patients With MDS". This is a prospective, open-label, multicenter, phase 1/2 study of TEW-7197 in patients with low and intermediate risk of myelodysplastic syndrome (MDS).
What is the current status of trial NCT03074006?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 9 participants. The study started on 2018-01-04. Estimated completion is 2019-12-31.
What interventions are being tested in trial NCT03074006?
The interventions under investigation include: TEW-7197 (DRUG).
Who is sponsoring clinical trial NCT03074006?
This trial is sponsored by MedPacto, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.